Ben Sasse, who has pancreatic cancer, reports that a new drug has shrunk his tumors, although it has also caused significant side effects. The drug is being discussed as a potential breakthrough in treating one of the deadliest forms of cancer. Reports suggest the drug may be improving survival rates for some pancreatic cancer patients, but details about its effectiveness and Sasse's specific situation are still emerging.